关键词：糖尿病；葡萄糖水平；高于；正常范围；BGM；血糖仪
摘 要：Diabetes is a disease that occurs when the body is unable to produce insulin or produces insulin in insufficient quantities, or when the glucose level in the body rises above the normal range. Insulin, a hormone produced by the pancreas, is used to process glucose, which acts as fuel for the tissues. BGM is the process of testing the concentration of insulin or glucose in the blood. A blood glucose meter is a small electronic device used to measure and display the blood glucose level. To measure the level of blood glucose, a small drop of blood is taken by pricking or piercing a finger with an instrument called a lancet. A drop of blood is then placed on a disposable blood glucose test strip and this is inserted into a blood glucose meter.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Rate of Incidence and Prevalence

07.1.1 Treatment Methods for Diabetic Patients

08. Market Segmentation by Product

08.1 Global Blood Glucose Test Strips Market

08.1.1 Market Size and Forecast

08.2 Global Blood Glucose Meters Market

08.2.1 Market Size and Forecast

08.3 Global Lancets Market

08.3.1 Market Size and Forecast

09. Geographical Segmentation

09.1 BGM Device Market in Americas

09.1.1 Market Size and Forecast

09.2 BGM Device Market in EMEA Region

09.2.1 Market Size and Forecast

09.3 BGM Device Market in APAC Region

09.3.1 Market Size and Forecast

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

17.1 Competitive Scenario

17.1.1 Key News

17.1.2 Mergers and Acquisitions

17.2 Market Share Analysis 2013

17.3 Other Prominent Vendors

18. Key Vendor Analysis

18.1 Abbott Laboratories

18.1.1 Key Facts

18.1.2 Business Overview

18.1.3 Business Segmentation by Revenue

18.1.4 Business Segmentation by Revenue 2011 and 2012

18.1.5 Geographical Segmentation by Revenue

18.1.6 Business Strategy

18.1.7 Key Information

18.1.8 SWOT Analysis

18.2 Arkray

18.2.1 Key Facts

18.2.2 Business Overview

18.2.3 Business Segmentation

18.2.4 Recent Developments

18.2.5 SWOT Analysis

18.3 Bayer HealthCare

18.3.1 Key Facts

18.3.2 Business Overview

18.3.3 Business Segmentation by Revenue 2013

18.3.4 Business Segmentation by Revenue 2012 and 2013

18.3.5 Geographical Segmentation by Revenue 2013

18.3.6 Business Strategy

18.3.7 Recent Developments

18.3.8 SWOT Analysis

18.4 F. Hoffmann-La Roche

18.4.1 Key Facts

18.4.2 Business Overview

18.4.3 Business Segmentation

18.4.4 Business Segmentation by Revenue 2012 and 2013

18.4.5 Geographical Segmentation by Revenue

18.4.6 Business Strategy

18.4.7 Key Information

18.4.8 SWOT Analysis

18.5 LifeScan

18.5.1 Key Facts

18.5.2 Business Overview

18.5.3 Product Segmentation

18.5.4 Geographical Segmentation

18.5.5 Business Strategy

18.5.6 Recent Developments

18.5.7 SWOT Analysis

19. Other Reports in this Series